ERBB2 and breast carcinoma: SBT-100 has broad range of efficacy against many human malignancies such as ER + PR+ breast cancer, HER2-amplified breast cancer, triple negative breast cancer (TNBC), pancreatic cancer, prostate cancer, glioblastoma, osteosarcoma, fibrosarcoma, and leukemia [143].